Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > COVID heart inflammation:
View:
Post by prophetoffactz on Nov 17, 2023 11:24am

COVID heart inflammation:

CZO's Dr. William Li is a scientist working on longCOVID. He published an article early in the COVID pandemic in the Washington Post with a former Commissioner of the US FDA warning about a potential wave of long-term illness from COVID:

"...detected an inflammation of the heart muscle in 60, despite the lack of a relevant preexisting condition."" Washington Post


"If covid-19′s vascular effects are widespread, the more than 20 million patients who have “recovered” could be living with serious damage to their blood vessels. That could unleash a global surge in vascular diseases, from stroke and atherosclerosis to myocarditis and heart attack.
 

Consider a recent study published in JAMA Cardiology, which looked at 100 patients who had recently recovered from covid-19. The researchers found some form of heart abnormality in 78 of these cases and detected an inflammation of the heart muscle in 60, despite the lack of a relevant preexisting condition."

Opinion | It’s time to focus on potential long-term organ damage from covid-19 - The Washington Post
Comment by boazklinghorn on Nov 17, 2023 12:01pm
As the stock is burning to the ground the Proph is still waxing poetic about fairies and unicorns.. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities